SARA MIERS: Open Payments
NPI 1457787400 · WAKE VILLAGE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,526 in 106 payments from 15 companies in 2025. Trend: 2023 $1,523 · 2024 $1,346 · 2025 $1,526
Food & beverage: $1,526
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $307 |
| ABBVIE INC. | 19 | $174 |
| Lilly USA, LLC | 15 | $156 |
| Abbott Laboratories | 7 | $150 |
| Amgen Inc. | 9 | $139 |
| GlaxoSmithKline, LLC. | 11 | $137 |
| Novo Nordisk Inc | 6 | $93 |
| Phathom Pharmaceuticals, Inc. | 5 | $86 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $80 |
| PFIZER INC. | 4 | $63 |
Products named: FARXIGA, MOUNJARO, FREESTYLE LIBRE 3, TRELEGY ELLIPTA, VOQUEZNA, UBRELVY, XIFAXAN, OTEZLA.
Industry payments across TX — which companies pay providers there.
